# Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors

> **NCT01014429** · PHASE1 · COMPLETED · sponsor: **Nerviano Medical Sciences** · enrollment: 21 (actual)

## Conditions studied

- Advanced or Metastatic Solid Tumors

## Interventions

- **DRUG:** NMS-1286937

## Key facts

- **NCT ID:** NCT01014429
- **Lead sponsor:** Nerviano Medical Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-10
- **Final completion:** —
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2012-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01014429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01014429, "Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01014429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*